- Lobbying
- Lobbying by American College of Medical Genetics
Lobbying Relationship
Bills mentioned
H.R.3441: Accurate Education for Prenatal Screenings Act
Sponsor: Jaime Herrera Beutler (R-Wash.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.34: 21st Century Cures Act
Sponsor: Suzanne Bonamici (D-Ore.)
H.R.4393: Advancing Access to Precision Medicine Act
Sponsor: Eric Swalwell (D-Calif.)
H.R.3235: Access to Genetic Counselor Services Act of 2019
Sponsor: Dave Loebsack (D-Iowa)
H.R.7059: Coronavirus Provider Protection Act
Sponsor: Phil Roe (R-Tenn.)
S.4249: A bill to ensure the protection of human genetic information collected...
Sponsor: Thom Tillis (R-N.C.)
S.3404: VALID Act of 2020
Sponsor: Richard M. Burr (R-N.C.)
H.R.6102: VALID Act of 2020
Sponsor: Diana DeGette (D-Colo.)
H.R.482: Newborn Screening Saves Lives Reauthorization Act of 2021
Sponsor: Lucille Roybal-Allard (D-Calif.)
S.350: Newborn Screening Saves Lives Reauthorization Act of 2021
Sponsor: Margaret Hassan (D-N.H.)
H.R.1439: Expanded Genetic Screening Act of 2021
Sponsor: Jackie Speier (D-Calif.)
H.R.2144: Access to Genetic Counselor Services Act of 2021
Sponsor: Brian Higgins (D-N.Y.)
S.1450: Access to Genetic Counselor Services Act of 2021
Sponsor: John Barrasso (R-Wyo.)
S.1666: VITAL Act of 2021
Sponsor: Rand Paul (R-Ky.)
H.R.4128: VALID Act of 2021
Sponsor: Diana DeGette (D-Colo.)
S.2209: VALID Act of 2021
Sponsor: Richard M. Burr (R-N.C.)
S.4348: FDASLA Act of 2022
Sponsor: Patty Murray (D-Wash.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Allison F. Kassir | Staff, Rep. McHale, OSD/DOD & HASC staff to Rep. P. McHale, OSD/DOD & HASC |
Lauren M. Donoghue | Staff/Press Assistant, Rep. Jeb Bradley |
John E. Howell | n/a |
Tara D. Chapman | n/a |
David J. Farber | n/a |
William C. Talmadge | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
U.S. House of Representatives
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
U.S. Senate
Health & Human Services - Dept of (HHS)
Food & Drug Administration (FDA)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate